Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma

Alt, M; Stecca, C; Lin, Y; Kazeem, G; Goluboff, ET; Sridhar, SS

Sridhar, SS (通讯作者),Univ Toronto, Princess Margaret Hosp, Princess Margaret Canc Ctr, Toronto, ON, Canada.

BMC CANCER, 2023; 23 (1):

Abstract

Background This retrospective analysis of data from clinical trials in metastatic urothelial carcinoma (mUC) was conducted to determine baseline patie......

Full Text Link